• REVOLUTIONISING

    the diagnosis and treatment of urinary tract infection (UTI)
  • REVOLUTIONISING

    the diagnosis and treatment of urinary tract infection (UTI)

Innovative PhenUtest point-of-care test

Results in under an hour including full antimicrobial susceptibility test.

Ground-breaking technology with the potential to transform the diagnosis and treatment of urinary tract infection, a common condition associated with billions of dollars of annual healthcare costs globally. In the US alone these costs are in the order of $44bn.

Innovative PhenUtest point-of-care test

Results in under an hour including a full antimicrobial susceptibility test

Ground-breaking technology with the potential to transform the diagnosis and treatment of urinary tract infection, a common condition associated with billions of dollars of annual healthcare costs globally. In the US alone these costs are in the order of $44bn.1

Accurate Results

  • Proprietary technology provides accurate results in less than an hour
  • For use in primary care, the community and emergency care
  • Expected to reduce hospitalisation and slow the growth of antimicrobial resistance (AMR)

Accurate Results

  • Proprietary technology provides accurate results in less than an hour
  • For use in primary care, the community and emergency care
  • Expected to reduce hospitalisation and slow the growth of antimicrobial resistance (AMR)
  • More than

    150M

    UTI infections a year globally, of which >71% of patients are women2, 3

  • More than

    150M

    UTI infections a year globally, of which >71% of patients are women2, 3

Current methods are time-consuming and often inaccurate

Current gold standard test take 48+ hours to deliver full antimicrobial susceptibility test (AST) results

Current methods are time-consuming and often inaccurate

Current gold standard tests take 48+ hours to deliver full antimicrobial susceptibility test (AST) results4

Latest News

PhenUtest Shortlisted for BioNow Start-Up Award 2023

Bath, UK, February 6 2024

Experienced medtech executive becomes CEO at Phenutest Diagnostics

Bath, UK, January 31 2023
  • 1.
    Zilberberg et al., outcomes of ER visits with complicated UTIs, 2022
  • 2.
    Flores-Mireles et al., UTI epidemiology, mechanisms and treatment, 2015
  • 3.
    Simmering et al., Hospitalisations for UTI and Associated Cost, 2017
  • 4.
    Xu et al., Review of Current and Developing UTI diagnostics, 2021
This test has not been approved or cleared by the U.S. Food and Drug Administration.
The performance characteristics of this test have not been established.

Biosciences Building, Crown Street
Liverpool, L69 7BE, UK

Contact us / Privacy Policy / Cookie Policy / © Copyright / Created by HTP Digital

Biosciences Building, Crown Street
Liverpool, L69 7BE, UK

Contact us / Privacy Policy / Cookie Policy / © Copyright / Created by HTP Digital